期刊文献+

HPLC鉴别乳酸左氧氟沙星中的乳酸 被引量:2

Identification of lactic acid in Levofloxacin lactate by HPLC
原文传递
导出
摘要 目的采用HPLC法鉴别乳酸左氧氟沙星中的乳酸。方法采用Agilent C18色谱柱(250 mm×4.6 mm,5μm),流动相为磷酸溶液(p H2.5)-乙腈(95∶5),流速1.0 m L·min^(-1),检测波长210 nm,柱温30℃。结果乳酸中D-乳酸和L-乳酸主峰的分离良好,分离度度>1.5;供试品色谱图中乳酸主峰的保留时间与D,L-乳酸对照品主峰的保留时间一致。结论HPLC法鉴别乳酸左氧氟沙星中乳酸的专属性强、重复性良好,可用于鉴别乳酸左氧氟沙星中的乳酸。 OBJECTIVE To establish an HPLC method for identification of lactic acid in Levofloxacin lactate. METHODS The Agilent C ls (250 mm× 4.6 mm, 5 μm) column was used with the mobile phase of phosphoric acid solution (pH2.5) - acetonitrile (95 : 5 ). The flow rate was 1.0 mL· min^-1, and the detection wavelength was 210 nm. The column temperature was 30 ℃. RESULTS D - lactic acid and L - lactic acid were well separated, and the separation degree was greater than 1.5. The test results showed that the relative retain time of peaks of lactic acid in the sample chromatogram and reference standard chromatogram were consistent. CONCLUSION The method is specific, accurate. And it can be used for quality control of Levofloxacin Lactate.
作者 黄玉兰
出处 《华西药学杂志》 CAS CSCD 2016年第6期631-633,共3页 West China Journal of Pharmaceutical Sciences
关键词 左氧氟沙星 乳酸左氧氟沙星 乳酸左氧氟沙星分散片 D-乳酸 L-乳酸 乳酸 鉴别 HPLC Levofloxacin Levofloxacin lactate Levofloxacin Lactate dispersible tablets D - Lactic acid L - Lactic acid Lactic acid Identification HPLC
  • 相关文献

参考文献2

二级参考文献21

  • 1顾海宁,蒋永祥,葛海泉.左旋氧氟沙星合成的新工艺研究[J].高校化学工程学报,2005,19(5):708-711. 被引量:19
  • 2唐建国.氟喹诺酮药物左氟沙星[J].国外医药(抗生素分册),1996,17(5):380-387. 被引量:43
  • 3Richard G A,Childs S,Fowler C,et al.A comparison of levofloxacin and ciprofloxacin for the treatment of complicated urinary tract infections[J].Clin.Infect.Dis.,1996,23:913.
  • 4Davis R,Bryson H M.Levofloxacin:a review of its antibacterial activity,pharmacokinetics and therapeutic efficacy[J].Drugs,1994,47(4):677-700.
  • 5Hayakawa I,Atarashi S,Yokohama S,et al.Optically active pyridobenzoxazne derivatives and intermediates thereof:EP,0206283[P].1986-06-20.
  • 6Katsu S,Shuichi Y,Isao H,et al.Optical resolution of(R,S)-3-acetoxymethyl-7,8-difluoro-2,3-dihydro-4H-[1,4]benzoxazine[J].Agric.Biol.Chem.,1987,51(5):1265-1270.
  • 7Mitscher L A,Padam N S,Chu D T,et al.Chiral DNA gyrase inhibitors.2.asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid[J].J.Med.Chem.,1987,30(12):2283-2286.
  • 8Mitscher L A,Chu D T.Process for preparation of racemete and optically active ofloxacin and related derivatives:US,4777253[P].1988-10-11.
  • 9Ye W D,Zhang W D,Yang Z H.Methods for prepraration of levofloxacin and ofloxacin:WO,123746[P].2005-12-29.
  • 10Rammhanrao D,Dwivedi S D.An improved process for the preparation of levofloxacin:WO,048889[P].2006-11-05.

共引文献6

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部